Physician profile
Cameron Dower
NPI 1740052117
$4,174.87
in general payments reported to CMS, 2019-2025
21 companies · $1,842 in 2025
The $1,842 reported for 2025 was more than what 92% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $2,333 · 2025: $1,842.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,990 · Education: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,989.89 |
| Education | $184.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $704.06 | 2024-2025 | Nemluvio, Aklief |
| Abbvie INC. | $595.43 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $489.09 | 2024-2025 | |
| Ucb, INC. | $342.03 | 2024-2025 | Bimzelx |
| Lilly USA, LLC | $332.60 | 2024-2025 | Ebglyss, Taltz, Olumiant |
| Incyte Corporation | $329.83 | 2024-2025 | Opzelura, Opzelura |
| Novartis Pharmaceuticals Corporation | $262.76 | 2024-2025 | |
| Janssen Biotech, INC. | $214.40 | 2024-2025 | Tremfya |
| Biofrontera INC. | $204.29 | 2024-2025 | Ameluz, Xepi, Bf-Rhodoled |
| Leo Pharma INC. | $199.69 | 2024-2025 | Adbry |
| Regeneron Healthcare Solutions, INC. | $96.13 | 2024-2025 | Libtayo, Dupixent |
| Genzyme Corporation | $95.47 | 2024-2025 | |
| Arcutis Biotherapeutics, INC. | $79.27 | 2024-2025 | Zoryve |
| Pfizer INC. | $44.94 | 2024-2025 | |
| Journey Medical Corporation | $39.96 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almirall LLC | $37.36 | 2025 | Seysara |
| Biowound Solutions, INC. | $28.99 | 2025 | Bio-Connekt |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $28.43 | 2024-2025 | Cabtreo |
| Organon LLC | $18.16 | 2025 | |
| Amgen INC. | $16.47 | 2024 | Otezla |
| E.R. Squibb & Sons, L.L.C. | $15.51 | 2025 | Sotyktu |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameron Dower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.